Asymmetric dimethylarginine (ADMA) is a naturally occurring inhibitor of nitric oxide synthesis that accumulates in a wide range of diseases associated with endothelial dysfunction and enhanced atherosclerosis. Clinical studies implicate plasma ADMA as a major novel cardiovascular risk factor. but the mechanisms by which low concentrations of ADMA produce adverse effects on the cardio... https://www.spidertattooz.com/NYX-Total-Control-Drop-Foundation-Brush-PROB22-p11165/